BeStock  
Stocks › Biotechnology › ACAD

ACADIA Pharmaceuticals ACAD

US equityMarket cap rank #2441Biotechnology
$17.11 −$0.48 (-2.73%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $17.12 +0.06%
Open$17.47
Prev close$17.59
Day range$17.05 – $17.79
Volume1.90M
Market cap$2.96B
P/E (TTM)8.1
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$342.29M+22.8% YoY
Operating profit$71.72M+100.6% YoY
Net profit$53.52M-25.4% YoY
Diluted EPS$0.31-26.2% YoY
Free cash flow$10.26M+141.2% YoY
Operating cash flow$11.50M

Revenue, last 8 quarters

$259.6MDec '24$244.3MMar '25$264.6MJun '25$278.6MSep '25$284.0MDec '25$268.1MMar '26$308.0MJun '26$342.3MSep '26

Net profit, last 8 quarters

$143.7MDec '24$19.0MMar '25$26.7MJun '25$71.8MSep '25$273.6MDec '25$3.6MMar '26$31.5MJun '26$53.5MSep '26

Diluted EPS by quarter

0.86Dec '240.11Mar '250.16Jun '250.42Sep '251.60Dec '250.02Mar '260.18Jun '260.31Sep '26

Free cash flow by quarter

$39.9MDec '24$-78.5MMar '25$162.5MJun '25$-24.9MSep '25$46.1MDec '25$28.8MMar '26$95.7MJun '26$10.3MSep '26

Annual revenue

$441.8MFY20$484.1MFY21$517.2MFY22$726.4MFY23$957.8MFY24$1.1BFY25

Profitability & balance sheet

Gross margin90.5%
Operating margin10.2%
Net margin30.1%
Return on equity31.4%
Return on assets23.2%
Return on invested capital28.2%
Current ratio3.82
Liabilities / assets22.7%
Cash & investments$976.45M
Total debt$57.32M
Net cash (debt)$919.12M
Free cash flow / sales15.0%

Where the revenue comes from

Quarter 2026/Q3

By business line

  • NUPLAZID$202.16M 59.1%
  • DAYBUE$140.13M 40.9%

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $342.29M $307.96M $268.06M $1.07B $283.99M
Total Operating Revenue $342.29M $307.96M $268.06M $1.07B $283.99M
Cost of Revenue $35.09M $28.32M $24.79M $89.00M $26.23M
Gross Profit $307.20M $279.64M $243.27M $982.51M $257.76M
Operating Expense $235.48M $241.81M $247.89M $877.70M $240.37M
Selling and Admin Expenses $159.20M $160.25M $171.02M $548.89M $155.62M
Research & Development $76.28M $81.56M $76.87M $328.80M $84.76M
Operating Profit $71.72M $37.84M -$4.62M $104.81M $17.39M
Net Non-Operating Interest Income (Expense) $8.42M $7.99M $8.06M $31.72M $8.33M
Non-Operating Interest Income $8.42M $7.99M $8.06M $31.72M $8.33M
Other Income (Expense) $300,000.00 $647,000.00 $542,000.00 $2.37M $596,000.00
Other Non-Operating Income (Expenses) $300,000.00 $647,000.00 $542,000.00 $2.37M $596,000.00
Pretax Profit $80.44M $46.47M $3.98M $138.90M $26.32M
Tax $26.92M $14.97M $344,000.00 -$252.10M -$247.25M
Net Profit $53.52M $31.50M $3.64M $391.00M $273.57M
Profit from Continuing Operations $53.52M $31.50M $3.64M $391.00M $273.57M
Net Income to Parent Company $53.52M $31.50M $3.64M $391.00M $273.57M
Net Income to Common Stockholders $53.52M $31.50M $3.64M $391.00M $273.57M
Basic EPS $0.31 $0.18 $0.02 $2.32 $1.62
Diluted EPS $0.31 $0.18 $0.02 $2.30 $1.60
Special Income (Charges) – – – $0.00 –
-Gain on Sale of Property/Plant/Equipment – – – $0.00 –

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $1.79B $1.74B $1.61B $1.56B $1.56B
Total Current Assets $1.27B $1.22B $1.10B $1.06B $1.06B
Cash and Cash Equivalents & Short-Term Investments $976.45M $956.47M $851.46M $819.69M $819.69M
-Cash and Cash Equivalents $322.37M $384.99M $282.21M $177.70M $177.70M
-Short Term Investments $654.08M $571.49M $569.25M $641.99M $641.99M
Receivables $178.32M $166.33M $148.38M $148.23M $148.23M
-Accounts Receivable $161.02M $150.64M $135.35M $121.46M $121.46M
-Accrued Interest Receivable $17.30M $15.69M $13.03M $26.77M $26.77M
Prepaid Assets $73.31M $69.37M $64.60M $59.53M $59.53M
Inventory $40.36M $32.37M $31.57M $34.67M $34.67M
Total Non-Current Assets $525.73M $518.36M $509.21M $502.08M $502.08M
Net PPE $85.87M $86.53M $60.93M $54.87M $54.87M
-Gross PPE $85.87M $86.53M $60.93M $64.35M $64.35M
Goodwill and Other Intangible Assets $135.48M $103.45M $106.17M $108.89M $108.89M
Non-Current Deferred Assets $226.72M $240.68M $249.62M $249.88M $249.88M
Other Non-Current Assets $77.65M $87.70M $92.49M $88.45M $88.45M
Total Liabilities $406.66M $436.29M $357.16M $336.81M $336.81M
Total Current Liabilities $332.22M $361.44M $305.52M $277.11M $277.11M
Payables $16.33M $44.57M $12.25M $11.21M $11.21M
-Accounts Payable $16.33M $44.57M $12.25M $10.90M $10.90M
Current Accrued Expenses $256.97M $267.22M $250.06M $208.70M $208.70M
Short-Term Debt and Capital Lease Obligation $14.53M $14.31M $11.79M $11.63M $11.63M
-Current Capital Lease Obligation $14.53M $14.31M $11.79M $11.63M $11.63M
Total Non-Current Liabilities $74.45M $74.86M $51.64M $59.69M $59.69M
Long Term Debt and Capital Lease Obligation $57.32M $59.55M $39.00M $40.55M $40.55M
-Long Term Capital Lease Obligation $57.32M $59.55M $39.00M $40.55M $40.55M
Other Non-Current Liabilities $17.12M $15.31M $12.64M $19.14M $19.14M
Total Equity $1.39B $1.31B $1.25B $1.23B $1.23B
Stockholders' Equity $1.39B $1.31B $1.25B $1.23B $1.23B
Capital Stock $17,000.00 $16,000.00 $16,000.00 $16,000.00 $16,000.00
-Common Stock $17,000.00 $16,000.00 $16,000.00 $16,000.00 $16,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $3.12B $3.09B $3.06B $3.04B $3.04B
Retained Earnings -$1.72B -$1.78B -$1.81B -$1.81B -$1.81B
Gains/Losses Not Affecting Retained Earnings -$2.94M -$958,000.00 -$563,000.00 $1.45M $1.45M
-Accumulated Depreciation – – – -$9.48M -$9.48M
-Total Tax Payable – – – $304,000.00 $304,000.00

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow $11.50M $100.78M $33.98M $109.84M -$48.73M
Net cash flow from continuing operations $11.50M $100.78M $33.98M $109.84M -$48.73M
Net Income from Continuing Operations $53.52M $31.50M $3.64M $391.00M $273.57M
Depreciation & Depletion & Amortization $3.65M $3.16M $2.99M $11.76M $2.92M
Deferred Tax $14.40M $9.77M -$94,000.00 – –
Change in Working Capital -$77.55M $39.46M $13.20M -$89.76M -$87.91M
-Change in Receivables -$12.02M -$17.96M -$153,000.00 -$43.54M -$8.80M
-Change in Inventory $1.36M $3.90M $78,000.00 -$18.20M -$4.89M
-Change in Prepaid Assets -$3.90M -$4.77M -$5.07M -$3.85M $1.34M
-Change in Payables and Accrued Expense -$64.75M $54.85M $24.90M -$24.55M -$79.24M
-Change in Other Current Assets $2.84M $2.61M $2.13M $5.81M $1.35M
-Change in Other Current Liabilities -$1.09M $822,000.00 -$8.68M -$5.44M $2.33M
Net cash flow from investing -$86.15M -$8.53M $66.28M -$302.56M -$55.87M
Net Cash Flow from Continuing Investing Activities -$86.15M -$8.53M $66.28M -$302.56M -$55.87M
Net PPE Purchase and Sale -$1.24M -$5.09M -$5.21M -$4.69M -$4.01M
Net Investment Purchase and Sale -$84.91M -$3.44M $71.49M -$199.04M -$51.86M
Financing Cash Flow $11.87M $10.49M $4.23M $49.88M $22.67M
Net Cash Flow from Continuing Financing Activities $11.87M $10.49M $4.23M $49.88M $22.67M
Net Common Stock Issuance $11.87M $10.49M $4.23M $49.88M $22.67M
Ending Cash Balance $330.21M $392.83M $290.06M $185.54M $185.54M
Net Change in Cash -$62.78M $102.75M $104.49M -$142.85M -$81.93M
Beginning Cash Balance $392.83M $290.06M $185.54M $328.36M $267.47M
Effect of Exchange Rate Changes $159,000.00 $27,000.00 $25,000.00 $26,000.00 $7,000.00
Free Cash Flow $10.26M $95.69M $28.77M $105.15M $46.10M
Net Intangibles Purchase and Sale – – $0.00 – –
Other Non-Cash Items – – – -$249.88M –
Net Business Purchase and Sale – – – -$98.84M –

Discussion

No comments yet — be the first to weigh in on ACAD.

Sign in to join the discussion.

Scroll to Top